Sullivan Edward Aloysius Jr. 4
4 · Comera Life Sciences Holdings, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Sullivan Edward Aloysius Jr.
Director
Transactions
- Award
Common Stock
2023-01-04$1.23/sh+10,979$13,504→ 19,665 total - Award
Warrants (right to buy)
2023-01-04$0.25/sh+10,979$2,745→ 10,979 totalExercise: $1.23From: 2023-01-04Exp: 2028-01-04→ Common Stock (21,958 underlying)
Footnotes (2)
- [F1]The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 10,979 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules.
- [F2]The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation.